Recursion

Ashwin Nandakumar and Ashwin Jainarayanan were working on their doctorates at adjacent departments in Oxford, but they didn’t know each other. Nandakumar, who was studying oncology, one day stumbled across…

Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments

Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B round, led by Data Collective (DCVC). Recursion started out in 2014 on…

Drug discovery startup Recursion raises $60 million in Series B from Data Collective